Successfully reported this slideshow.
We use your LinkedIn profile and activity data to personalize ads and to show you more relevant ads. You can change your ad preferences anytime.

Prediction of Restenosis After PCI with Contemporary Drug-Eluting Stents

1,922 views

Published on

SOLACI Congress 2012, Mexico. Find more presentations on our website.

Published in: Health & Medicine
  • Be the first to comment

Prediction of Restenosis After PCI with Contemporary Drug-Eluting Stents

  1. 1. HEART INSTITUTE
  2. 2. Prediction of restenosis after PCI with contemporary drug-eluting stents DR. ASHOK SETH FRCP (LOND), FRCP (EDIN), FRCP (IREL), FACC, FSCAI, FCSI, DSc. CHAIRMAN CHIEF OF CARDIOLOGYCHAIRMAN – CARDIOLOGY COUNCIL, FORTIS GROUP OF HOSPITALS FORTIS ESCORTS HEART INSTITUTE PRESIDENT – CARDIOLOGICAL SOCIETY OF INDIAHEART INSTITUTE
  3. 3. Restenosis After BA and Stent • Most significant problem for years • DES have dramatically reduced instent restenosis. • Low rates of ISR in DES still a problem.HEART INSTITUTE
  4. 4. Classification of Restenosis (Mehran et al. Circulation 1999;100:1872-8)HEART INSTITUTE
  5. 5. Incidence of DES ISR 12% 11-12% 10% 8% 6-7% 6% 5-6% 4% 2% 0% Native Denovo Real Life Patients Real Life Patients Lesion 1st Gen DES 1st Gen DES 2nd Gen DESHEART INSTITUTE
  6. 6. Delayed Restenosis • Late ‘Catch Up’ Modest increase in NIH beyond 1-year on IVUS study follow up. – Delayed healing response – Persistent biological reaction – Hypersensitivity reaction to durable polymer ‘Therefore longer term follow up’HEART INSTITUTE
  7. 7. Stent Thrombosis vs Restenosis • ISR Presents as effort angina while stent thrombosis usually presents MI. • TVF within 30-days is usually stent thrombosis while ISR is usually later. • DES has delayed the time frame of ISR • Both ISR and Stent thrombosis may co-exist.HEART INSTITUTE
  8. 8. Definitions and Classification of Restenosis and Stent Thrombosis Dangas et al. J Am Coll Cardiol. 2010;56(23):1897-1907HEART INSTITUTE
  9. 9. Possible Mechanisms of Restenosis After DES Dangas et al. J Am Coll Cardiol. 2010;56(23):1897-1907HEART INSTITUTE
  10. 10. Biologic Factors • Drug Resistance • Hyper sensitivity – Allergy to Nickel / Molybdenum of 316 to stenosis steel. – RADAR STUDY (Research on Adverse Drug / Device Adverse Reports) - Drug Hypersensitivity for DES.HEART INSTITUTE
  11. 11. RADAR (Research on Adverse Drug Events & Reports) (Nebeker JR et al. J Am Coll Cardiol 2006;47:175-181) • 5783 AE after DES • 261 Hypersensitivity Reaction • 17 DES cause of HS • 4 Died of stent thrombosis between 4-18 monthsHEART INSTITUTE
  12. 12. HEART INSTITUTE
  13. 13. Mechanical Factors (Dangas et al. J Am Coll Cardiol. 2010;56(23):1897-1907) Stent Under expansionHEART INSTITUTE
  14. 14. Mechanical Factors (Dangas et al. J Am Coll Cardiol. 2010;56(23):1897-1907) Stent Fracture • Incidence: 2-8% • Rigid closed cell stents, overlapping stents, longer stents, vessel tortuousity, angulation and torsionHEART INSTITUTE
  15. 15. Technical Factors • ‘Geographical Miss’ • Uncovered atherosclerotic plaque • Baro trauma outside stented segmentHEART INSTITUTE
  16. 16. Technical Factors • Stent Gap • Gap between two overlapping stents • Bends and CurvesHEART INSTITUTE
  17. 17. Predictors of ISR or TLR After DES Implantation Dangas et al. J Am Coll Cardiol. 2010;56(23):1897-1907HEART INSTITUTE
  18. 18. Risk Scoring to Predict TLR in DES (Stolker et al. Circ Cardiovasc Interv. 2010;3:327-334)HEART INSTITUTE
  19. 19. Predictors of DES Restenosis (Corbett et al. Circulation. 2006;114:II_688) • 2269 lesions 1283 patients (2003-2005) • Angio FU 70% DES ISR : SES 16.9% : PES 16.8%HEART INSTITUTE
  20. 20. Morphologic Pattern of SES, PES, and BMS ISR Dangas et al. J Am Coll Cardiol. 2010;56(23):1897-1907HEART INSTITUTE
  21. 21. Clinical and Angiographic Outcomes After Percutaneous Treatment of DES ISR Dangas et al. J Am Coll Cardiol. 2010;56(23):1897-1907HEART INSTITUTE
  22. 22. Morphological Pattern of Restenosis as a Predictor of Repeat ISR after DES ISR Treatment (Dangas et al. JACC 2010; 56: 1897-907) Repeat ISR TLR 60% 57% 50% 40% 30% 23% 20% 18% 10% 10% 0% Focal ISR Non Focal ISR DES ISRHEART INSTITUTE
  23. 23. Treatment of DES ISR ‘Difficult Disease Process’ • IVUS or other imaging essential to understand the underlying mechanism. • OPTIONS – Balloon angioplasty – DEB – DES : Same DES : Different DES – VBT – CABGHEART INSTITUTE
  24. 24. Algorithm for the Treatment of DES Restenosis Dangas et al. J Am Coll Cardiol. 2010;56(23):1897-1907HEART INSTITUTE
  25. 25. Conclusion • Though DES has lowered the restenosis rates of PCI, the increased complexity of lesions being treated has resulted in DES ISR being an important problem. • The predictors of restenosis in DES era are similar to the BMS era, but DES ISR can occur later and tends to be more focal and this has a better prognosis than BMS ISR. • Diffuse DES ISR is a very ‘difficult animal’ as the pathophysiology and causative mechanism of DES ISR are in many cases unclear and hence treatment options are ‘hit and trial’. • Further studies new DES and Bioresorbable stents are on the way to overcome this important problem.HEART INSTITUTE

×